Article
Study on H3K9 acetylation modification and TLR9 immune regulation mechanism in patients…
medRxiv · 2020 · Hai-Peng Zhu
Key facts
| Title | Study on H3K9 acetylation modification and TLR9 immune regulation mechanism in patients with anti-HBV treatment using thymosin a1 combined with entecavir |
|---|---|
| First author | Hai-Peng Zhu |
| Journal | medRxiv |
| Published | Nov 1, 2020 |
| DOI | 10.1101/2020.10.31.363127 |
| Devices mentioned | K011853, K973350, K990017, K990149, K990150, K990161, K990162, K990282, K990391, K990394, K990424, K990587 and 2 more |
| Product codes mentioned | CIG, MQM, DHR, JJX, JJY, JLX, KQP |
At a glance
- 10–99 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1